[go: up one dir, main page]

NO873244L - Legemiddel. - Google Patents

Legemiddel.

Info

Publication number
NO873244L
NO873244L NO87873244A NO873244A NO873244L NO 873244 L NO873244 L NO 873244L NO 87873244 A NO87873244 A NO 87873244A NO 873244 A NO873244 A NO 873244A NO 873244 L NO873244 L NO 873244L
Authority
NO
Norway
Prior art keywords
pct
sec
date
drug
pub
Prior art date
Application number
NO87873244A
Other languages
English (en)
Other versions
NO175620B (no
NO873244D0 (no
NO175620C (no
Inventor
Hansjoerg Eibl
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO873244D0 publication Critical patent/NO873244D0/no
Publication of NO873244L publication Critical patent/NO873244L/no
Publication of NO175620B publication Critical patent/NO175620B/no
Publication of NO175620C publication Critical patent/NO175620C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
NO873244A 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel NO175620C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3542893 1985-12-04
DE3606631 1986-02-28
PCT/EP1986/000706 WO1987003478A2 (en) 1985-12-04 1986-12-04 Medicaments

Publications (4)

Publication Number Publication Date
NO873244D0 NO873244D0 (no) 1987-08-03
NO873244L true NO873244L (no) 1987-10-01
NO175620B NO175620B (no) 1994-08-01
NO175620C NO175620C (no) 1994-11-09

Family

ID=25838509

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873243A NO174877C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
NO873244A NO175620C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO873243A NO174877C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning

Country Status (15)

Country Link
US (2) US4837023A (no)
EP (4) EP0248062B1 (no)
JP (2) JPH0637393B2 (no)
AT (2) ATE75608T1 (no)
CA (2) CA1338627C (no)
DE (4) DE19375061I2 (no)
DK (2) DK172954B1 (no)
ES (2) ES2032755T3 (no)
FI (2) FI873363A7 (no)
GR (2) GR3002487T3 (no)
HU (2) HU208143B (no)
IE (2) IE59777B1 (no)
NO (2) NO174877C (no)
PT (2) PT83873B (no)
WO (2) WO1987003480A2 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
ATE137973T1 (de) * 1989-08-10 1996-06-15 Sandoz Ag Phospholipide zur behandlung der multiplen sklerose
US5182271A (en) * 1989-08-10 1993-01-26 Sandoz Ltd. Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
US5506217A (en) * 1991-04-25 1996-04-09 The University Of British Columbia Phosphonates as anti-cancer agents
SG47844A1 (en) * 1991-07-04 1998-04-17 Asta Medica Ag A process for the preparation of alkylphosphocholines and the production thereof in pure form
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs
US6254879B1 (en) 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
AU7044894A (en) * 1993-06-10 1995-01-03 University Of North Carolina At Chapel Hill, The (phospho)lipids for combatting hepatitis b virus infection
AU7648994A (en) 1993-09-09 1995-03-27 Imutec Pharma Inc. Immunomodulating compositions from bile
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
DE69535758D1 (de) 1994-08-29 2008-07-03 Univ Wake Forest Lipid-analoge zur behandlung von viralen infektionen
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
WO1996024598A1 (en) * 1995-02-10 1996-08-15 The University Of British Columbia [4-hexadecyl-3-methoxy-butyl] phosphonic acid and its protein conjugates useful as anti-cancer agents
BR9607967A (pt) 1995-03-16 1998-01-13 Imutec Pharma Inc Uso de composições imunomodulares extraídas da bile para o tratamento das desordens do sistema imunológico fabricação do medicamento e emprego do mesmo
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
SE9701912D0 (sv) * 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US7582678B2 (en) * 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
ATE215817T1 (de) * 1998-01-22 2002-04-15 Zentaris Ag Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
IL137672A0 (en) 2000-08-03 2001-10-31 Dpharm Ltd Derivatives of branched-chain lipophilic molecules and uses thereof
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
US6960738B2 (en) * 2001-05-29 2005-11-01 Koninklijke Philips Electronics N.V. Metal-ceramic bond
JP4714413B2 (ja) * 2001-08-31 2011-06-29 トムソン ライセンシング オーディオビジュアルストリームのためのシーケンスカウンタ
WO2003090757A1 (en) * 2002-04-26 2003-11-06 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
AR058397A1 (es) 2005-12-19 2008-01-30 Zentaris Gmbh Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos
WO2008074573A1 (en) * 2006-12-20 2008-06-26 Alphaptose Gmbh Topical dosage form comprising tri-substituted glycerol compounds
JP2011057647A (ja) * 2009-09-14 2011-03-24 Adeka Corp 化粧料
ES2759584T3 (es) 2011-06-24 2020-05-11 Gri Bio Inc Prevención y tratamiento de afecciones inflamatorias
CN102491994B (zh) * 2011-12-07 2014-10-15 宁波九胜创新医药科技有限公司 一种胆碱磷酸烷基酯的制备方法
CN107206086B (zh) * 2014-12-09 2022-03-18 Gri生物有限公司 炎性病况的预防和治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
JPS60184092A (ja) 1984-03-01 1985-09-19 Kao Corp リン酸エステルおよびその製法

Also Published As

Publication number Publication date
WO1987003480A3 (en) 1988-02-25
ES2038215T3 (es) 1993-07-16
IE59777B1 (en) 1994-04-06
IE863177L (en) 1987-06-04
CA1280369C (en) 1991-02-19
ATE75608T1 (de) 1992-05-15
DE3641491A1 (de) 1987-09-17
DK398587D0 (da) 1987-07-30
NO175620B (no) 1994-08-01
JPH0637393B2 (ja) 1994-05-18
NO873243L (no) 1987-10-02
PT83872B (pt) 1989-01-17
DK393187A (da) 1987-07-28
PT83873B (pt) 1989-01-17
HUT44441A (en) 1988-03-28
EP0225608A3 (de) 1987-10-28
EP0230575A3 (de) 1987-12-02
HU203201B (en) 1991-06-28
DE19375061I2 (de) 2008-11-20
JPS63501719A (ja) 1988-07-14
DE3679908D1 (de) 1991-07-25
IE863176L (en) 1987-06-04
HU208143B (en) 1993-08-30
NO873243D0 (no) 1987-08-03
FI873363L (fi) 1987-08-03
NO873244D0 (no) 1987-08-03
WO1987003478A2 (en) 1987-06-18
NO174877C (no) 1994-07-27
NO175620C (no) 1994-11-09
EP0248062A1 (de) 1987-12-09
IE59778B1 (en) 1994-04-06
FI873364A7 (fi) 1987-08-03
DK393187D0 (da) 1987-07-28
EP0230575A2 (de) 1987-08-05
US5049552A (en) 1991-09-17
PT83872A (de) 1987-01-01
DE3641379A1 (de) 1987-09-03
GR3005168T3 (no) 1993-05-24
CA1338627C (en) 1996-10-01
EP0248047A1 (de) 1987-12-09
EP0248047B1 (de) 1991-06-19
EP0248062B1 (de) 1992-05-06
PT83873A (de) 1987-01-01
HUT44431A (en) 1988-03-28
WO1987003478A3 (en) 1987-09-24
EP0225608A2 (de) 1987-06-16
JPH0859677A (ja) 1996-03-05
NO174877B (no) 1994-04-18
WO1987003480A2 (en) 1987-06-18
DK172954B1 (da) 1999-10-18
JP2857084B2 (ja) 1999-02-10
FI873363A0 (fi) 1987-08-03
DK398587A (da) 1987-07-30
GR3002487T3 (en) 1992-12-30
FI873364A0 (fi) 1987-08-03
FI873363A7 (fi) 1987-08-03
US4837023A (en) 1989-06-06
ES2032755T3 (es) 1993-03-01
ATE64529T1 (de) 1991-07-15

Similar Documents

Publication Publication Date Title
NO873244D0 (no) Legemiddel.
FI873113L (fi) Tvaettmedelskomposition.
ATE100668T1 (de) Chemische formulierungen.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
FI875039A7 (fi) Terapeuttiset koostumukset eläinlääketieteellistä käyttöä varten.
NO822841L (no) Insekticid middel med virkning mot bladlus.
ES2019634B3 (es) Terapia con clorfeniramina.
LV10870A (lv) Jauni fosfolipidu atvasinajumi
NO873628D0 (no) 2,3-dihydro-1h-fenalen-2-amino-forbindelser som antipsykotiske legemidler.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
IT8722591A0 (it) Formulazione farmaceutica contenente gemfibrozilmicroincapsulato.
NO874743D0 (no) Terapeutiske blandinger for veterinaerbruk.
IT208775Z2 (it) Siringa per l'anestesia intraligamentosa.
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.
IT8322815A0 (it) Formulazioni farmaceutiche adattivita' antisettica.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees